SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma
SUCCINCT：一项开放标签、单臂、非随机的 II 期临床试验，旨在评估吉西他滨和顺铂化疗联合舒尼替尼作为晚期尿路上皮癌患者一线治疗方案的疗效。
期刊:
影响因子:
doi:10.1016/j.eururo.2014.11.003
Geldart, Thomas; Chester, John; Casbard, Angela; Crabb, Simon; Elliott, Tony; Protheroe, Andrew; Huddart, Robert A; Mead, Graham; Barber, Jim; Jones, Robert J; Smith, Joanna; Cowles, Robert; Evans, Jessica; Griffiths, Gareth
